ArticleOncotarget2016

miR-22 targets YWHAZ to inhibit metastasis of hepatocellular carcinoma and its down-regulation predicts a poor survival.

Ming Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.